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Objective: Childhood cardiometabolic disease risk (CMD) has been associated with
short sleep duration. Its relationship with other aspects of sleep should also be
considered, including social jetlag (SJL) which represents the difference between a
person’s social rhythms and circadian clock. This study investigated whether childhood
CMD risk is associated with sleep duration, sleep disturbances, and SJL.
Study Design: The observational study included 332 children aged 8–10 years (48.5%
female). The three independent variables were sleep duration, sleep disturbances, and
SJL. SJL was calculated as the variation in hours between the midpoint of sleep during
free (weekend) days and work/school days. Eleven cardiometabolic biomarkers were
measured, including central blood pressure, lipids, glycated hemoglobin, arterial wave
reflection, and glucose. Underlying CMD risk factors were identified using factor analysis.
Results: Four underlying CMD risk factors were identified using factor analysis: blood
pressure, cholesterol, vascular health, and carbohydrate metabolism. Neither sleep
disturbances nor sleep duration were significantly associated with any of the four CMD
factors following adjustments to potential confounders. However, SJL was significantly
linked to vascular health (p = 0.027) and cholesterol (p = 0.025).
Conclusion: These findings suggest that SJL may be a significant and measurable
public health target for offsetting negative CMD trajectories in children. Further studies
are required to determine biological plausibility.
Keywords: circadian clock, social clock, activity behavior, sleep duration, vascular, social jetlag (SJL), metabolic
INTRODUCTION
Cardiometabolic disease (CMD) etiology is insidious, with the trajectory beginning during
childhood or potentially pre-birth (1–4). Childhood is important because biological systems are
highly malleable, responding to the interplay between genetic and environmental cues (3, 4).
Environmental cues include exposure to the activity behaviors of sleep, sedentary time and physical
activity (2–4). The importance of these activity behaviors during childhood has been emphasized
through shifts in public health policy. For example, the recent Canadian 24-hMovement Guidelines
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advised on the amount of time children should engage in each
activity behavior across the day in a digestible format (5). With
respect to sleep, the guidelines recommend that children and
youth (aged 5–13 years) should sleep for 9–11 h each night.
However, while insufficient sleep length is related to increased
CMD risk in children (6–9), other aspects of sleep, such as
social jetlag (SJL), should be considered. Social jetlag is defined
as the discrepancy between an individual’s biological and social
rhythms and, in children, is calculated as the total difference in
the midpoints of sleep on weekdays vs. weekend days (10, 11).
Physiological processes, including glucose metabolism and
blood pressure, display a circadian rhythm that is controlled
by the internal circadian biological clock (12, 13). For children
living in today’s society, social obligations, particularly school
schedules, can lead to SJL and disruption of circadian rhythms.
Studies in children and early adolescence have reported
associations between SJL and measures of body composition
(14, 15). One of the studies found a statistically non-significant
association between SJL and CMD risk (15). CMD risk was
calculated as the linear sum of z scores for systolic blood pressure
(SBP), high-density lipoprotein cholesterol (HDL), triglycerides
(TG), waist circumference, and homeostatic model of insulin
resistance (HOMA). This linear combination approach, which
assumes equal weighting for each variable, is prone to
multicollinearity and fails to recognize that some risk factors
cluster (16). Alternatively, a data driven approach, such as
factor analysis, can determine the appropriate weighting for each
predictor, eliminate the problem ofmulticollinearity, and identify
risk factor clusters (17).
This study investigated whether CMD risk in preadolescent
children is associated with sleep duration, sleep disturbances, and
SJL. Novel and conventional CMD risk stratification biomarkers
were used in factor analysis to classify CMD risk factor clusters.
We evaluated the hypothesis that SJL, independent of sleep
duration and sleep disturbances, would be associated with CMD
risk factor clusters.
METHODOLOGY
This registered cross-sectional study (ACTRN12614000433606)
meets the conditions of the New Zealand Health and Disability
Ethics Committees (HDEC: 14/CEN/83), and accords with
STROBE reporting guidelines (18).
Participants
Between April 2015 and April 2016, children (aged 8–
10 years) were recruited from schools within three regions
(Canterbury, Otago, Wellington) across New Zealand. Schools
Abbreviations: AIx, augmentation index; β, beta; cSBP, central systolic blood
pressure; CSHQ, Children’s Sleep Habits Questionnaire; DBP, diastolic blood
pressure; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HDL,
high density lipoproteins; HR, heart rate; LDL, low density lipoproteins;
mmHg, mmol/L, millimoles per liter; %, percentage; mmHg, millimeters of
mercury; n, sample size; SBP, systolic blood pressure; SD, standard deviation;
SES, socioeconomic scale; SJL, Social jetlag; TC, total cholesterol; STROBE,
Strengthening the Reporting of Observational Studies in Epidemiology; TG,
triglycerides; WD, weekday; WE, weekend.
were classified according to a decile system based on the
predominant socioeconomic status (SES) of attending students.
We categorized schools as low SES (Deciles 1–5) or high SES
(Deciles 6–10), and randomly sampled from these strata. All
children were eligible to participate, unless they had experienced
orthopedic injury in the previous 3 months or had been
prescribed cardiovascular medications. An information packet
was provided to eligible children, and parental/guardian consent
and child assent were obtained prior to data collection.
Experimental Design
Data collection took place at the participating schools.
Cardiometabolic measurements were made on a single day
(Monday–Thursday) between the 9:00 and 12:00 o’clock hours.
Children were asked to refrain from exercise for 24 h prior to
measurement, be adequately hydrated, and have fasted for at least
3 h. The primary caregiver was asked to complete a questionnaire
at home, which provided demographic and sleep habits data.
Only children with complete sleep data and cardiometabolic
health information were included in the analyses.
Independent Variables
The three assessed sleep variables were sleep duration, sleep
disturbances, and SJL. The participant’s caregiver was asked to
report the times their child typically rested and woke on both
school days and free (weekend) days. The mean of sleep duration
was calculated using a ratio of twoweekend days to five weekdays.
Social jetlag was estimated as the total discrepancy between
the midpoints of sleep on weekend days vs. weekdays (10).
Single items of customary school/weekday sleep display sufficient
concurrent validity with actigraphy and diary records (19).
The Children’s Sleep Habits Questionnaire (CSHQ) was
utilized to estimate sleep disturbances, for which adequate test–
retest reliability, discriminant validity, and internal consistency
have been reported (20). The questionnaire consisted of 33
questions on a 7-point Likert-type scale ranging from Always
(1) to Never (7) with higher scores indicative of greater sleep
disturbances. The sum of all 33 scored CSHQ questions (with
a potential range of 33–99), was used to calculate a Total Sleep
Disturbance score. A Total Sleep Disturbance score >41 was
applied to signify troubled sleep, as this cutoff has been revealed
to precisely identify 80% of children with a clinically detected
sleep disorder. Only the Total Sleep Disturbance score was used
for this study (20).
Dependent Variables
Eleven cardiometabolic variables were measured: central
hemodynamics [augmentation index (AIx), central systolic blood
pressure (cSBP), heart rate (HR)], peripheral hemodynamics
[diastolic blood pressure (DBP) and SBP], cardiac blood markers
[HDL, TG, total cholesterol (TC), low density lipoproteins
(LDL)], metabolic blood markers [glycated hemoglobin (HbA1c)
and fasting blood glucose (FBG)].
Peripheral and Central Hemodynamics
Pulse wave analysis (BP+, Uscom, Sydney, Australia) was applied
to gauge all central hemodynamic variables. Oscillometric
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pressure waveforms were recorded by a single operator on
the left upper arm following 20min of undisturbed supine
rest (21). Each measurement cycle was ∼40 s, comprising
a 10 s suprasystolic recording, followed by a brachial blood
pressure recording. Utilizing a validated transfer function, an
aortic pressure waveform was generated from which cSBP was
estimated. Arterial wave reflection (AIx) was estimated from the
suprasystolic waveform by means of the formula AIx = (P3 –
P0)/(P1 – P0), where P0 denotes the pressure at the onset of
the pulse, P1 the peak pressure of the incident wave, and P3
the peak pressure of the reflective wave. This index explains the
relative height of the reflected pressure wave when compared
to the incident waveform. The recordings with a quality signal
were the only ones accepted (sign to noise ratio of >3dB). Two
measurements were recorded, with a third if blood pressures
differed by >5 mmHg or the AIx by >4%. Our group has
reported acceptable between-day reliability for cSBP (ICC: 0.90),
cSBP (ICC: 0.94) and AIx (ICC: 0.71) (22).
Cardiac and Metabolic Blood Markers
Capillary blood was collected to measure fasting HbA1c
(A1CNow+, PTS Diagnostics) (23), and TG, FBG, TC, HDL and
LDL (CardioChek PA, PTS Diagnostics) (23).
Sample Size
Factor analysis was utilized to calculate the sample size, for
which two dissimilar methods have been advocated based on:
(i) the ratio of participants to variables, or (ii) a minimum total
sample size (24). (ii) The recommended minimum participant
to item ratio ranges from 5:1 to 10:1. For eleven variables, a
minimum of 110 participants would be required using the 10:1
ratio. Minimum sample sizes, ranging from 50 to 400 have been
recommended. Comfrey and Lee state that, “the adequacy of
sample size might be evaluated very roughly on the following
scale: 50–very poor; 100–poor; 200–fair; 300–good; 500–very
good; 1000 or more–excellent” (24). The n = 332 for the current
study meets Comfrey and Lee’s “Good” criteria (24).
Statistical Analysis
The Jamovi (v1.1.3.0) platform was used for statistical analysis.
Participant demographic data were reported as mean and
standard deviation. Regression outcomes are reported as beta (β)
with 95% confidence intervals (95% CI). The significance level
was set a priori for all statistical procedures at α = 0.05. The
corresponding author (NC) had full access to the data in the study
and was responsible for the integrity of the dataset. Anonymized
data will be shared upon reasonable request.
CMD risk factors were identified using factor analysis (17).
Factor analysis is a data-driven approach that can be used
to identify how cardiometabolic variables cluster together.
The assumption is that for a collection of observed variables
there is a set of latent variables (factors) that can explain
the interrelationships among those variables. This data-driven
approach confers several advantages beyond simply summing
Z scores: (i) accurate determination of predictor weighting;
(ii) control for collinearity; and (iii) provision of additive
information by the factors, beyond the individual components
(17). The number of factors (i.e., latent variables) was determined
by the minimum eigenvalue principle of greater than one for a
factor analysis of the correlation matrix. The implication being
that if an eigenvalue is greater than one the derived dimension
captures less variability in the data than any single variable.
Following orthogonal varimax rotation, the correlation between
the derived factors and the underlying variables were used to
interpret (label) each factor. We used a loading of >0.40 to
interpret the factor pattern.
The associations between CMD risk and the three sleep
measures were examined using linear regression analyses. To
account for the clustered data (students within schools), we
used Gaussian family generalized estimating equations with
robust standard errors (25). Following the assessment of
model assumptions, separate univariate analyses examined the
association between each independent (average sleep duration,
SJL, sleep disturbances) and each dependent variable (CMD risk
factors), followed by a multivariable analysis. Two multivariable
models were specified. Model 1 included the three sleep variables
without further adjustments. Model 2 was additionally adjusted
for school decile rating, ethnicity, age, and sex.
RESULTS
Participants
Complete sleep and cardiometabolic data were available for
n= 332 (Figure 1). These children were not discernibly different
from the full 392 participants (9.6 ± 1.1 years, 48.5% female,
29.2% overweight, 51.5% low decile school). The demographic
data are presented in Table 1. Most of the participants (92.8%,
n= 308) slept for at least 9 h nightly, and the mean of the
total sleep duration did not differ for the week compared to the
weekend (10.1 vs. 10.1 h, p = 0.453). Less than half (39.2%) the
students reported disturbed sleep. All but two of the participants
that reported going to bed later on the weekend (mean: 42min,
95% CI: 44, 50), and 97% (n= 330) also reported waking later on
the weekend (42min, 95% CI: 37, 46). Consequently, the average
SJL was 44.4± 31.7min, and 36.1% had >1-h SJL.
Sleep and Cardiometabolic Disease Risk
The outcomes from factor analysis are reported in Table 2. The
table displays the association of each variable with the four
factors. The factors are labeled, in order of variance explained
by the model: Blood Pressure, Cholesterol, Vascular Health and
Carbohydrate Metabolism (CHO-MET). For example, Factor 1,
which explains 23% of the cumulative variance, is labeled Blood
Pressure because the variables which load most strongly onto the
factor are the blood pressures.
Table 3 displays the univariate models. Sleep disturbances
and sleep duration were not significantly associated with any
CMD risk factor. Social jetlag was associated with cholesterol
(β:−0.110, 95% CI: −0.416, −0.008) and vascular health
(β: 0.162, 95% CI: 0.103, 0.501). Multivariable models 1 and
2 are shown in Table 3. Following adjustments for potential
confounders (Model 2), SJL retained significant associations with
cholesterol (β:−0.126, 95% CI: −0.448, −0.030) and vascular
health (β: 0.125, 95% CI: 0.027, 0.438) risk factors.
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FIGURE 1 | Student recruitment flow diagram.
DISCUSSION
The major finding of this study is that neither sleep disturbances
nor sleep duration significantly correlated with any of the four
CMD risk factors. However, SJL was significantly associated with
cholesterol and vascular health factors. These findings suggest
that SJL may be an important sleep characteristic with respect to
CMD risk in children.
Strengths and Limitations
The limitations and strengths of the current study are discussed
here to provide context to the discussion that follows. First, we
attempted to ensure the findings are generalizable to children
across New Zealand by recruiting participants from three regions
across the country. However, the findings may not generalize to
populations outside of New Zealand. Second, this was a cross-
sectional study and association is not causality. Longitudinal
and intervention analyses are warranted to validate the results
of the current study. Third, parent-report questionnaires were
used to collect the sleep data rather than objective measures.
While concurrent validity has been reported for the single item
TABLE 1 | Participant demographics stratified by sex (n = 332).
All Male Female
Categorical variables n (%) n (%) n (%)
n 332 (100.0) 171 (51.5) 161 (48.5)
Female 161 (48.5) 0 (0.0) 161 (100.0)
Ethnicity
New Zealand European 269 (81.0) 143 (83.6) 126 (78.3)
Māori 37 (11.1) 16 (9.4) 21 (13.0)
Pacific 22 (6.6) 10 (5.8) 12 (7.5)
Not recorded 4 (1.2) 2 (1.2) 2 (1.2)
School year
4 (7–8 years old) 72 (21.7) 35 (20.5) 37 (23.0)
5 (8–9 years old) 93 (28.0) 51 (29.8) 42 (26.1)
6 (9–10 years old) 105 (31.6) 54 (31.6) 51 (31.7)
7 (10–11 years old) 62 (18.7) 31 (18.1) 31 (19.3)
School decile
Low (≤5) 171 (51.5) 89 (52.0) 82 (50.9)
High (>5) 161 (48.5) 82 (48.0) 79 (49.1)
Obesity status
Overweight-obese 235 (70.8) 121 (70.8) 114 (70.8)
Non-overweight 97 (29.2) 50 (29.2) 47 (29.2)
Sleep
>9 h of sleep 308 (92.8) 159 (93.0) 149 (92.5)
>1 h of SJL 120 (36.1) 60 (35.1) 60 (37.3)
Sleep disorder 130 (39.2) 65 (38.0) 65 (38.0)
Continuous variables Mean (SD) Mean (SD) Mean (SD)
Sleep outcomes
WD sleep duration, hours 10.1 (0.89) 10.1 (0.89) 10.1 (0.91)
WE sleep duration, hours 10.1 (1.03) 10.1 (0.99) 10.1 (1.08)
Sleep duration, hours 10.1 (0.84) 10.1 (0.83) 10.1 (0.86)
Social jetlag, hours 0.74 (0.53) 0.68 (0.50) 0.80 (0.55)
Cardiometabolic outcomes
Age, years 9.55 (1.13) 9.54 (1.06) 9.57 (1.20)
Systolic blood pressure, mmHg 101 (7.44) 101 (7.44) 101(8.18)
Diastolic blood pressure, mmHg 61.8 (6.24) 61.2(6.16) 62.4 (6.35)
Central systolic blood pressure,
mmHg
93.5 (7.73) 93.2 (7.19) 93.7 (8.27)
Total cholesterol, mmol/L 3.57 (0.61) 3.5 (0.64) 3.64 (0.57)
Low-density lipoprotein cholesterol,
mmol/L
1.85 (0.51) 1.78 (0.48) 1.91(0.53)
High-density lipoprotein cholesterol,
mmol/L
1.47 (0.36) 1.51 (0.39) 1.43 (0.32)
Augmentation index, % 55.8 (15.2) 55.5 (15.0) 56.1 (15.5)
Heart rate, bpm 74.9 (11.5) 72 (10.2) 77.8 (12.3)
Fasting blood glucose, mmol/L 5.05 (0.39) 5.13 (0.39) 4.96 (0.38)
Triglycerides, mmol/L 1.47 (0.36) 0.839 (0.47) 0.892 (0.38)
Glycated hemoglobin, % 5.12 (0.31) 5.11 (0.31) 5.12 (0.31)
WD, weekday; WE. weekend; n, sample size; mmHg, millimeters of mercury; mmol/L,
millimoles per liter; %, percentage; SD, standard deviation, effect size (Cohen’s d).
sleep surveys compared to actigraphy and diary data (19), future
studies with objective assessments are warranted. Last, while our
CMD risk model did include both FBG (short term glycemic
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control) and HbA1c (chronic glycemic control), insulin was not
measured. There is some evidence that, at least in obese children,
hyperinsulinemia precedes impaired fasting glucose control (13,
26). Future CMD risk models may be improved through the
addition of insulin. The key strengths included the use of a data-
driven approach for characterizing CMD risk, the co-assessment
of three sleep variables thought to be important to a child’s
TABLE 2 | Factor analysis and eigenvalues (n = 332).





Systolic blood pressure 0.90 0.06 0.16 −0.01
Diastolic blood pressure 0.89 −0.01 0.04 −0.05
Central systolic blood pressure 0.88 −0.02 −0.08 0.04
Total Cholesterol 0.01 0.92 −0.01 0.07
Low density lipoproteins 0.02 0.70 0.03 0.03
High density lipoproteins 0.00 0.55 −0.14 −0.45
Augmentation index 0.18 −0.04 −0.73 0.02
Heart rate 0.27 0.10 0.68 0.02
Fasting blood glucose 0.04 −0.13 0.51 −0.05
Triglycerides 0.15 −0.10 −0.02 0.73
Glycated hemoglobin −0.17 0.15 −0.10 0.68
Eigenvalue 2.5 1.7 1.3 1.2
% variance explained 23 16 12 11.0
Cumulative variance 23 39 51 62
Bold numbers represent variables with a factor loading 0.4.
health, and our relatively large and representative cohort of New
Zealand-based preadolescents.
Comparison to the Literature
A number of studies in adults have reported positive (i.e.,
negative) associations between CMD risk and SJL (13, 26, 27).
Though only one known study has examined the association
between CMD risk and SJL in children (15). Cespedes Feliciano
et al. (15) reported a non-significant association between CMD
risk Z scores and SJL for both girls (β = 0.07, 95% CI: −0.02
to 0.15) and boys (β = 0.00, 95% CI: −0.08 to 0.08). One
potential explanation for the conflicting findings between the
Cespedes Feliciano et al. study (15) and current study is the
difference in sample characteristics, including the recruitment
of older children (12–17 year vs. 8–10 years, respectively).
However, considering CMD risk has been associated with SJL
in various adult populations this explanation is unlikely. A
more likely explanation pertains to methodological differences.
For the current study, we measured a comprehensive and
diverse mix of eleven cardiometabolic parameters and used
factor analysis to identify risk factor clusters (17). Using
this approach we found that SJL was associated with the
factors we labeled “cholesterol” and “vascular health,” but not
“blood pressure” and “CHO-metabolism.” Cespedes Feliciano
et al. (15) divided their sample of 479 adolescents by sex
(breakdown not provided) and characterized CMD risk using
composite z scores for waist circumference, SBP, HDL, TG,
and HOMA. This linear combination method would lack the
sensitivity of the data-driven approach used in the current
study as it assumes equal weighting for each variable, is prone
TABLE 3 | Linear associations between cardiometabolic risk factors and sleep measures (n = 332).
Univariate (n = 332) Multivariate (Model 1) (n = 332) Adjusted (Model 2) (n = 332)
β LCI UCI P ES β LCI UCI P ES β LCI UCI P ES
Factor 1. Blood pressure
Average sleep duration 0.002 −0.125 0.132 0.953 0.002 0.015 −0.113 0.147 0.793 0.012 0.026 −0.102 0.164 0.648 0.021
Sleep score 0.044 −0.011 0.025 0.425 0.263 0.040 −0.012 0.025 0.473 0.237 0.043 −0.011 0.025 0.442 0.254
Social jetlag 0.092 −0.029 0.377 0.093 0.049 0.091 −0.034 0.375 0.102 0.048 0.065 −0.086 0.332 0.251 0.501
Factor 2. Cholesterol
Average sleep duration −0.002 −0.132 0.127 0.969 −0.002 −0.013 −0.146 0.115 0.813 −0.010 0.019 −0.110 0.156 0.735 0.016
Sleep score −0.034 −0.024 0.012 0.532 −0.205 −0.029 −0.023 0.013 0.604 −0.165 −0.022 −0.022 0.015 0.691 −0.130
Social jetlag −0.110 −0.416 −0.008 0.041 −0.058 −0.111 −0.415 −0.005 0.045 −0.056 −0.126 −0.448 −0.030 0.025 −0.065
Factor 3. Vascular health
Average sleep duration −0.085 −0.226 0.027 0.122 −0.073 −0.069 −0.207 0.046 0.212 −0.058 −0.056 −0.197 0.065 0.321 −0.047
Sleep score 0.068 −0.007 0.029 0.215 0.415 0.048 −0.010 0.026 0.386 0.290 0.032 −0.013 0.032 0.557 0.196
Social jetlag 0.162 0.103 0.501 0.003 0.088 0.155 0.089 0.488 0.005 0.084 0.125 0.027 0.438 0.027 0.066
Factor 4. CHO-MET
Average sleep duration −0.058 −0.198 0.061 0.296 −0.048 −0.051 −0.192 0.069 0.357 −0.042 −0.026 −0.164 0.101 0.638 −0.022
Sleep score 0.017 −0.015 0.021 0.751 0.103 0.004 −0.018 0.019 0.948 0.022 −0.016 −0.021 0.015 0.776 −0.093
Social jetlag 0.097 −0.020 0.389 0.076 0.052 0.094 −0.027 0.384 0.089 0.049 0.031 −0.149 0.266 0.577 0.016
Univariate: specify the sleep measures (sleep duration, sleep disturbances, and social jet lag) separately (separate mode); Model 1: unadjusted multivariable (sleep duration, sleep
disturbances, and social jet lag); Model 2: Model 1 adjusted for age, sex, ethnicity, socioeconomic status.
n, sample size; β, beta; LCI, lower confidence interval; UCI, upper confidence interval; P, p-value; ES, effect size (Cohen’s d).
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to multicollinearity, and fails to recognize that risk factors
cluster (16).
SJL, but not sleep duration or sleep disturbances, was
associated with CMD risk. This finding is particularly surprising
considering that both sleep-related problems and short sleep
duration have previously been associated with CMD risk (6–
9). One potential explanation is the lack of co-consideration of
SJL in previous studies. However, a more likely explanation is
statistical in nature, particularly with respect to sleep duration.
In the current study, 93% of children reported having slept
for the recommended >9 h each night. While these data were
self-reported, it remains highly likely that the number of short
sleepers in the current study was low. The restricted range in the
data likely limited the capacity to detect an association between
sleep duration and CMD risk (28). Therefore, future pediatric
sleep research should consider utilizing more objective measures
of sleep in children (e.g., actigraphy).
We found that SJL correlated with vascular health and
cholesterol factors, but not the blood pressure or CHO-
metabolism factors. This finding is perhaps somewhat surprising
when considering that SJL may lead to disruption of circadian
rhythms in glucose metabolism and blood pressure, and have
negative consequences for the regulation of these processes
(12, 13). However, it should be acknowledged that while
the vascular health factor was primarily driven by AIx,
a measure of arterial wave reflection, FBG did load on
to this factor. It is plausible that SJL disrupts metabolic
pathways, and that these disruptions impair vascular function
and hemodynamic parameters, including increased arterial
wave reflection. Further research is warranted to determine
biological plausibility for the relationship between SJL and CMD
risk in children.
Implications
There has been a recent shift in public health policy to
acknowledge childhood activity behaviors in the context of the
entire 24 h day (5). With respect to sleep, it is recommended that
children and youth sleep for 9–11 h each night. Even though short
sleep duration is linked to increased CMD risk in children (6–9),
there are other aspects of sleep that should also be considered
in the context of 24 h activity behavior. In particular, findings
from the current study suggest that SJL contributes to CMD in
children. The current findings are strengthened by the fact that
93% of the children in the current study reported having slept the
recommended minimum 9h of sleep (5). Despite most children
achieving an adequate duration of sleep, SJL remained associated
with CMD risk. Considering that SJL is arguably a readily
modifiable target, i.e., ensuring children maintain consistent
and chronotype-driven sleep–wake cycles, further research is
warranted to ascertain causality and to determine whether SJL-
based interventions improve cardiometabolic outcomes. Another
area that warrants future attention is the exploration of sex-
specific effects. In the current study, we did not stratify our data
by sex as the smaller sample would have been insufficient for
the factor analysis. Our group and others have acknowledged sex
to moderate the relationship between SJL and health outcomes,
such as body composition (14, 15) and cardiorespiratory fitness
(29). Hence, the causal relationship between SJL and CMD
risk may differ by sex justifying the need for tailored sex-
specific interventions.
CONCLUSIONS
This study examined the independent associations between sleep
disturbances, sleep duration, and SJL with CMD risk in pre-
adolescent children. We found that SJL, but not sleep duration or
sleep disturbances, was associated with CMD risk. These results
suggest that SJL may be a significant and quantifiable public
health target for offsetting negative CMD trajectories in children.
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